×
A Dose-Outcome Analysis of Risperidone PDF
$ 40.00
A Dose-Outcome Analysis of Risperidone PDF quantity
$ 40.00
×
Evaluation of Trazodone and Quetiapine for Insomnia: An Observational Study in Psychiatric Inpatients PDF
$ 40.00
Evaluation of Trazodone and Quetiapine for Insomnia: An Observational Study in Psychiatric Inpatients PDF quantity
$ 40.00
×
A 12-Week Single-Blind Trial of Quetiapine for the Treatment of Mood Symptoms in Adolescents at High Risk for Developing Bipolar I Disorder PDF
$ 40.00
A 12-Week Single-Blind Trial of Quetiapine for the Treatment of Mood Symptoms in Adolescents at High Risk for Developing Bipolar I Disorder PDF quantity
$ 40.00
×
How Many Criteria Should Be Required to Define the DSM-5
$ 40.00
How Many Criteria Should Be Required to Define the DSM-5 Mixed Features Specifier in Depressed Patients? PDF quantity
$ 40.00
×
Self-Injurious Skin Picking: Clinical Characteristics and Comorbidity PDF
$ 40.00
Self-Injurious Skin Picking: Clinical Characteristics and Comorbidity PDF quantity
$ 40.00
×
A Survey of Patients' Knowledge About Lithium Therapy in the Elderly PDF
$ 40.00
A Survey of Patients' Knowledge About Lithium Therapy in the Elderly PDF quantity
$ 40.00
×
Longitudinal Predictive Validity of the DSM-5 Anxious Distress Specifier for Clinical Outcomes in a Large Cohort of Patients With Major Depressive Disorder PDF
$ 40.00
Longitudinal Predictive Validity of the DSM-5 Anxious Distress Specifier for Clinical Outcomes in a Large Cohort of Patients With Major Depressive Disorder PDF quantity
$ 40.00
×
Comparison Between the Montgomery-Asberg Depression Rating Scale-Self and the Beck Depression Inventory II in Primary Care PDF
$ 40.00
Comparison Between the Montgomery-Asberg Depression Rating Scale-Self and the Beck Depression Inventory II in Primary Care PDF quantity
$ 40.00
×
Residual Symptoms and Relapse: Mood, Cognitive Symptoms, and Sleep Disturbances PDF
$ 40.00
Residual Symptoms and Relapse: Mood, Cognitive Symptoms, and Sleep Disturbances PDF quantity
$ 40.00
×
The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies PDF
$ 40.00
The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies PDF quantity
$ 40.00
×
"Subthreshold" Depression: Is the Distinction Between Depressive Disorder Not Otherwise Specified and Adjustment Disorder Valid? PDF
$ 40.00
"Subthreshold" Depression: Is the Distinction Between Depressive Disorder Not Otherwise Specified and Adjustment Disorder Valid? PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
